A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry

NCT05566249 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-10-06

No results posted yet for this study

Summary

This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.

Conditions

Interventions

DEVICE

ArtiSential

Articulating laparoscopic instrument

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER
  • Seoul St. Mary's Hospital

    collaborator OTHER
  • Chonnam National University Hospital

    collaborator OTHER
  • Severance Hospital

    collaborator OTHER
  • Seoul National University Bundang Hospital

    collaborator OTHER
  • Uijeongbu St. Mary Hospital

    collaborator OTHER
  • LivsMed

    collaborator UNKNOWN
  • Samsung Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-12-31
Completion
2029-12-31
FDA Device
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05566249 on ClinicalTrials.gov